SillaJen Faces Delisting Despite New Owner's Capital Injection
Shareholders Protest Exchange’s Decision
Oncolytic virus firm SillaJen, which hoped to get back on track and resume stock trading after it found a new owner last year, is set to be delisted from Korea’s Kosdaq market as the exchange makes a preliminary decision.